RETRA is another small-molecule which have shown to activate a series of p53- regulated genes, specifically suppressing mutant p53-bearing tumor cells in vitro and in mouse xenografts, as reported by reported by Chumakov’s group in 2008 (Figure 3) [92]. The gene discussed is TP53; the disease is neoplasm.